Zhifeng Zhao, PhD
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study (NCT07685704) | Zhifeng Zhao, PhD | 2026-07-01 |
| Evaluation of Fluoxetine for Refractory Constipation With Somatic Symptom Disorder Features (NCT06506136) | Zhifeng Zhao, PhD | 2025-09-01 |
| Fluoxetine for Refractory Constipation (NCT06750445) | Zhifeng Zhao, PhD | 2020-01-01 |
Track Zhifeng Zhao, PhD automatically
Every clearance here is in the API, with alerts when new ones post.